Belen Kornfeld

UNSW Sydney, The University of Notre Dame Australia

Papers

2

Total Citations

14

H-Index

2

About

Dr. Belen Kornfeld is a head and neck surgeon whose research focuses on advancing transoral robotic surgery (TORS) for the treatment of HPV-associated oropharyngeal squamous cell carcinoma (OPSCC). Her major contributions center on demonstrating the oncological safety and functional benefits of TORS-based therapy, providing critical evidence for this emerging treatment paradigm. In her landmark 2024 study, Dr. Kornfeld presented a comprehensive 10-year retrospective analysis of TORS outcomes, showing that the approach achieves excellent oncological control while preserving quality of life—work that has already garnered 10 citations. She has further established TORS as a well-defined treatment modality requiring specialized surgical expertise, with her research highlighting the distinctive skill set needed to optimize both oncological and functional results. Dr. Kornfeld’s work is particularly significant given the rising incidence of HPV-related OPSCC and the need for de-escalation strategies that maintain cure rates while reducing treatment morbidity. Her contributions are shaping surgical practice in Australia and beyond, positioning TORS as a standard-of-care option for appropriately selected patients.

Research Focus

Key Achievements

2
H-Index
2
Papers
14
Total Citations
7
Avg Citations/Paper
🏆 Most Cited Paper
Oncological outcomes post transoral robotic surgery (TORS) for HPV-associated oropharyngeal squamous cell carcinoma, a single-centre retrospective Australian study
10 citations · 2024
📈 Most Prolific Year: 2024 (2 Papers)
🤝 Key Collaborators: 14
🏛 Institutions: UNSW Sydney, The University of Notre Dame Australia

Top Papers

  1. 1
  2. 2

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago